Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells
- PMID: 8557625
- DOI: 10.1074/jbc.271.2.1016
Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells
Abstract
MCF-7 human breast cancer cells are commonly used to model tissues responsive to estrogens and antiestrogens. We examined the effects of estradiol and the antiestrogen ICI 182780 on MCF-7 cell proliferation and insulin-like growth factor binding protein 3 (IGFBP-3) gene expression. ICI 182780-induced growth inhibition was associated with increased transcription of the IG-FBP-3 gene, increased IGFBP-3 mRNA abundance, and increased IGFBP-3 protein accumulation in the conditioned medium. The growth stimulatory effect of estradiol was associated with opposite effects, and the correlation between cellular proliferation and IGFBP-3 mRNA abundance was strong (r = -0.91). Recombinant IGFBP-3 inhibited basal and estradiol-stimulated MCF-7 cell proliferation, and an IGFBP-3 antisense oligodeoxynucleotide abolished antiestrogen-induced growth inhibition. These results provide evidence for an estradiol and antiestrogen-regulated IGFBP-3 growth inhibitory autocrine pathway in MCF-7 cells.
Similar articles
-
A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780.Cell Growth Differ. 1996 Nov;7(11):1501-6. Cell Growth Differ. 1996. PMID: 8930399
-
Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.Growth Horm IGF Res. 2006 Aug;16(4):224-39. doi: 10.1016/j.ghir.2006.06.005. Epub 2006 Aug 8. Growth Horm IGF Res. 2006. PMID: 16893667
-
Regulation of IGFBP-3 expression in breast cancer cells and uterus by estradiol and antiestrogens: correlations with effects on proliferation: a review.Prog Growth Factor Res. 1995;6(2-4):495-501. doi: 10.1016/0955-2235(95)00036-4. Prog Growth Factor Res. 1995. PMID: 8817694 Review.
-
Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line.Breast Cancer Res Treat. 1999 Jun;55(3):231-42. doi: 10.1023/a:1006274712664. Breast Cancer Res Treat. 1999. PMID: 10517168
-
EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium.J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):51-84. doi: 10.1016/s0960-0760(99)00065-5. J Steroid Biochem Mol Biol. 1999. PMID: 10418981 Review.
Cited by
-
Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis.J Cell Physiol. 2000 Apr;183(1):1-9. doi: 10.1002/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J. J Cell Physiol. 2000. PMID: 10699960 Free PMC article. Review.
-
IGFBP-3, a marker of cellular senescence, is overexpressed in human papillomavirus-immortalized cervical cells and enhances IGF-1-induced mitogenesis.J Virol. 2004 Jun;78(11):5720-7. doi: 10.1128/JVI.78.11.5720-5727.2004. J Virol. 2004. PMID: 15140969 Free PMC article.
-
Genetics, chemistry, and function of the IGF/IGFBP system.Endocrine. 2000 Apr;12(2):121-36. doi: 10.1385/ENDO:12:2:121. Endocrine. 2000. PMID: 10905372 Review. No abstract available.
-
Acquired resistance to tamoxifen is associated with loss of the type I insulin-like growth factor receptor: implications for breast cancer treatment.Cancer Res. 2012 Jul 1;72(13):3372-80. doi: 10.1158/0008-5472.CAN-12-0684. Epub 2012 May 9. Cancer Res. 2012. PMID: 22573715 Free PMC article.
-
Tyrosine kinase signalling in breast cancer: insulin-like growth factors and their receptors in breast cancer.Breast Cancer Res. 2000;2(3):170-5. doi: 10.1186/bcr50. Epub 2000 Mar 6. Breast Cancer Res. 2000. PMID: 11250706 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous